Lithium can be toxic if not used properly. Further, the research is still in the early stages and it is unlikely that a ...

Plasma p-tau181 is a promising biomarker that can help identify Alzheimer's disease pathology and distinguish those who are at risk for conversion to dementia.

One of neurologist Anelyssa D’Abreu’s least favorite tasks is giving her patients a dreaded diagnosis: early-stage ...

TSPO levels rise early in Alzheimer’s and persist throughout disease. Targeting this biomarker could open new treatment options. TSPO, a major marker of brain inflammation, may offer a way to detect ...

Right now more than 7 million Americans have Alzheimer's and that figure is expected to grow to 13 million by the year 2050.

New Alzheimer’s drugs known as anti-amyloid therapies may slow disease progression—but they also carry serious risks, ...

Auditory hallucinations are the hearing of sounds, usually human voices, that are not there. Visual hallucinations involve seeing things that do not exist. It can rarely be seen in patients with ...

The rate of Alzheimer’s diagnosis has declined steadily in recent decades, but as baby boomers age, the number of new cases ...